Symbol="SLNO"
AssetType="Common Stock"
Name="Soleno Therapeutics Inc"
Description="Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of rare diseases. The company is headquartered in Redwood City, California."
CIK="1484565"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS"
Address="1235 RADIO ROAD, SUITE 110, REDWOOD CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="47612700"
EBITDA="-26836000"
PERatio="None"
PEGRatio="0"
BookValue="1.359"
DividendPerShare="0"
DividendYield="0"
EPS="-2.91"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.531"
ReturnOnEquityTTM="-1.738"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="12.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.494"
EVToRevenue="-"
EVToEBITDA="0.516"
Beta="0.113"
num_52WeekHigh="6.2"
num_52WeekLow="0.85"
num_50DayMovingAverage="4.799"
num_200DayMovingAverage="3.129"
SharesOutstanding="9992200"
DividendDate="2017-10-06"
ExDividendDate="None"
symbol="SLNO"
open="4.74"
high="5.00"
low="4.54"
price="4.98"
volume="286438.00"
latest_trading_day="2023-08-23"
previous_close="4.66"
change="0.32"
change_percent="6.8670%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="15"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="85"
Volume_recent_avg="85304"
Change_recent_avg="0.01"
Delta_recent_avg="0.35"
Variance_recent_avg="0.18"
Change_ratio_recent_avg="0.4"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="85"
Aroon_momentum_negative="15"
image_negative_thumbnail_id_1="492"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0113.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="538"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0061.jpeg"
image_positive_thumbnail_id_1="618"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0090.jpeg"
image_positive_thumbnail_id_2="599"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0109.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1202"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
